source
- Congressional panel warns US rare-disease lead is eroding and calls for supportive policiesA Congressional advisory panel has urged the U.S. government to adopt policies that would help rare disease drug development, including a finalized FDA platform designation and the use of novel tri…
- House passes FDA Modernization Act 3.0 to push update of animal testing regulationsThe U.S. House approved the FDA Modernization Act 3.0, a bill aimed at modernizing preclinical testing rules. The legislation requires the FDA to revise regulations that still reference animal tes…